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Hydrolysis of cyclosporin A (CsA) was studied in order to clarify the still undefined point of attack of the acidic
degradation. Among ether extractable and water-soluble products formed from CsA in HCl, two open-chain pep
tides were isolated by high-performance liquid chromatography which were identified as the deca- and nonapeptides
deriving from CsA through the hydrolytic cleavage of amino acid residue 11 and both residues 11 and 10, respec-
tively. Identification was carried out by fast atom bombardment tandem mass spectrometry.
INTRODUCTION MATERIALS AND METHODS
Cyclosporin A (CsA), the well-known immunosuppres-
sant,l is a cyclic undecapeptide. Metabolism of this
peptide has been widely investigated and more than 30
compounds have been reported to be formed from CsA
in uitro andfor in uiuo.2 However, little attention has
been given to the possible hydrolytic degradation of
CsA, probably because inability of hydrolytic enzymes
to degrade cyclic peptides has been reported3'4.
The hydrolytic cleavage of CsA by acids was
described by the authors who first identified the
primary structure of the cyclic undecapeptide CsA.5
Conditions utilized by these authors and by others6
were rather exhaustive, being selected to degrade the
peptide structure completely. To the best of our know-
ledge nobody has ever isolated open-chain peptides
longer than tetrapeptides from CsA degradation, so that
the site of the first hydrolytic attack of the CsA mol-
ecule is still undefined.
In this paper we describe the isolation by high-
performance liquid chromatography (HPLC) and iden-
tification by fast atom bombardment tandem mass
spectrometry (FAB MSiMS) of two open-chain peptides
among the products of CsA acid hydrolysis. The com-
pounds, named decapeptide and nonapeptide, contain
the l-10 and 1-9 residues of CsA, respectively, and
show amino acid sequences unmodified with respect to
that of CsA. This new finding and the formation of iso-
cyclosporin A (isoCsA) by hydrolysis, as already re-
ported by others,T e suggest the peptide bond between
residues 1 and 1 1 of CsA to be the first one undergoing
cleavage under acidic conditions. Identification of the
two mentioned oligopeptides may be of relevance for
the understanding of the possible degradative metabo-
lism of CsA.
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Materials
CsA was a generous gift of Dr G. Corbetta (Sandoz
S.p.A., Milan, Italy). 3-Nitrobenzyl alcohol was from
Aldrich Chimica (Milan, Italy). Deuterated solvents
were from Merck (Darmstadt, Germany). Other
reagents were of analytical grade. Solvents for high-
performance liquid chromatography (HPLC) were used
after being degassed and filtered using 0.45 pm filters.
Standard isoCsA was prepared and purified as
described by Rùegger et al.5 by methansulphonic acid
treatment of CsA, followed by silicic acid column chro-
matography. Purity of the compound was checked by
thinJayer chromatography (TLC) using Silicagel 60
Frrn plates (Merck, Darmstadt, Germany) eluted with
chloroform-methanol (98:2, vlv) containing loA acetic
acid (Ro 0.19) and by HPLC under the conditions
described below (retention time 85 min).
Cyclosporin A hydrolysis
Hydrolysis of CsA was carried out by mixing 1 pmol of
pure CsA (dried from an ethanolic solution) with I ml
of 3 M HCl. The sample was heated at 60 "C for 5 h and
then dried under vacuum using a Savant centrifuge with
mild heating (45 "C). The residue was dissolved with 1
ml of methanol-water (1 :1, v/v) and extracted twice
with I ml of diethyl ether. After evaporation of the
organic solvent under nitrogen the residue was again
dissolved in methanol-water. Both this solution and the
aqueous phase were analysed by HPLC.
HPLC analysis
A System Gold liquid chromatograph (Beckman Instru-
ments Inc., Palo Alto, California), with two dual-piston
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pumps (Mod. 126) and a variable double-beam ultra-
violet (UV) detector (Mod. 166), was used. The appar-
atus was computer controlled (IBM, PS/50) and the
System Gold software was used for the analysis of data.
Peptide separation was carried out using a Beckman
ODS Ultrasphere column (150 x 4.6 mm, 5 pm) eluted
with 0.06% aqueous trifluoroacetic acid (TFA) (A) and
0.052% TFA in acetonitrile-water (80: 20, vlv) (B), per-
forming a linear gradient of B from 0 to 100% in 105
min.1o The flow rate was 0.5 ml min-1, and the UV
detector was set at 210 nm. Peaks of interest were col-
lected and the solvent was evaporated under vacuum
using a Savant centrifuge system.
FAB mass spectrometric analYsis
In order to obtain information on the molecular weight
of the unknown peptides spectra by FAB mass spec-
trometry were recorded using a Finnigan MAT95
double-focusing mass spectrometer equipped with a
caesium gun, recording positive ions and operating at
an ion accelerating voltage of 5 kV. The caesium ions
were accelerated through 22 kV. The spectra were
recorded from mf z 100 to mlz 1500 at 5-10 s per decade.
The instrument was operated with a resolution of 1300
(10% valley). 3-Nitrobenzyl alcohol was used as matrix
as previously reported by Paroni et a1.11 for the analysis
by FAB mass spectrometry of CsA and its metabolites.
Dried fractions from HPLC were dissolved with
methanol-water (1 :1, v/v) and 1 pl aliquots were
analysed. In order to exchange mobile hydrogens with
Time (min)
deuterium the dried samples were dissolved in a 1:1
mixture of deuterated methanol-water and the FAB
spectra were recorded using deuterated nitrobenzyl
alcohol as the matrix.
To obtain additional structural information,
collision-induced dissociation (CID) spectra of the
protonated molecular ion [M + H] * of the peptides
were also recorded by introducing helium as collision
gas into the first field-free region. The collision gas pres-
sure in the collision cell was adjusted to attenuate the
primary ion beam by 70%. The CID spectra were
obtained using the field-controlled BIE linked scan in
profile mode at 10 s per decade.
Nuclear magnetic resonance analysis
A Bruker AM-500 (Bruker Instruments, Silberpreiten,
Germany) operating at 500 MHz was used. Tetra-
methylsilane as the chemical shift reference was set at 0
ppm. Spectra of the decapeptide and nonapeptide were
resistered in deuterated water.
RESULTS AND DISCUSSION
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Figure 1. HpLC chromatogram of the aqueous phase obtained after hydrolysis of CsA. A, B and C conespond to compounds.with reten-
tioi times of 65,75 and gb-min, respectively. CsA under these analytical conditions had a retention time of 105 min and was absent in the
aqueous pnase.
HPLC analysis of the water-soluble compounds
obtained by CsA hydrolysis under conditions generally
used for the detection of oligopeptidesto showed the
presence of relevant peaks probably originating from
compounds with rather high molecular weight andlor
low polarity, at retention times ranging from 65 to 90
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min, shorter than that of CsA (105 min). Peak area
attributable to these compounds in the HPLC chro-
matogram corresponded, to 37% of the total area, the
remaining area being associated with peaks with shorter
retention times (Fig. 1). Assuming for all compounds an
unchanged molar absorption with respect to that of
CsA, these compounds represented about 30% of the
hydrolysed CsA. Qualitative GC/MS analysis under
conditions described for the detection of amino acidsl2
suggested that part of CsA (10-15%) had been hydro-
lysed completely; as described by others who used
stronger hydrolytic conditions all amino acids that con-
stitute the CsA chain were identified, excluding
MeBmt.13
Compounds giving rise to the HPLC peaks shown in
Fig. 1 were collected and taken to dryness. Analysis by
FAB mass spectrometry of those with retention times of
65 and 75 min gave rise to spectra (Fig. 24) with
[M + H]* ions at mfz 981 and 1108, suggesting that
they might derive from CsA by hydrolytic cleavage of
the MeBmtr-MeValrl peptide bond followed by the
loss of the MeVal11 or of both MeValll and Mel-eu,lo
respectively. The compound at retention time 85 min
behaved as IsoCsA prepared according to Rùegger er
a/.' both by TLC and HPLC, and its FAB mass spec-
trum showed the [M + H]* ion at mf z 1203. The struc-
ture of compounds giving rise to peaks at retention
times of 69 and 79 min is still under investigation.
The presence of ions atmlz 1108 and 981 in the FAB
mass spectra recorded for the crude residue of the
aqueous phase before HPLC analysis ensured that
acidic conditions used for the HPLC purification were
Figure 2. Mass spectra of the compounds with retention time 65
min and 75 min before (A) and after (B) treatmenr with deuterated
water-methanol (1 :1, v/v).
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Figure 3. CID spectrum of the compound with retention time 75 min using helium as collision gas. The main observed fragmentatton
reported on the spectrum. Among the indicated ions of the b series only those in bold characters are oresent in the ClD.
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Figure 4. CID spectrum of the compound with retention time 65 min using helium as collision gas.
not responsible for the formation of the peptides and
that no further hydrolysis of these peptides occurred by
drying the HPLC fraction containing TFA.
When spectra of the purified compounds were re-
corded aftér exchange of hydrogens with deuterium, the
[M + H] * signal was shifted by 7 mass units for both
cHa o *5
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- 
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compounds (Fig. 28) instead of the 8 units that would
be eipected on the basis of six NH and one OH groups
in thè hypothesized structures plus the protonating
hydrogen. This may derive from a rapid exchange of
"itn".itt" protonating deuterium 
or of the deuterium of
the hydroiy group with protium ions within the mass
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Scheme 1
Decapeptide Nonapeptide
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spectrometer.to However, we cannot exclude the possi-
bility that either before or during the ionization piocess
isomerization may occur at the MeBmt residue, leading
to a tetrahydrofuran ring13 with consequent loss of thé
mobile hydrogen of the hydroxy group of MeBmt.
Figure 3 shows the CID spectrum of the [M + H] *ion of the decapeptide. Major ions observed in the spec-
trum at mlz 269,340, 468, 567, 693 and 963 corres-
ponded to those expected for the b series of the
hypothetical decapeptide. For the y series only the
intense ion at mlz 840, corresponding to the yr,,, was
noted. Identification of other relevant ions derivine
from internal fragmentation of primary daughter ions ii
also reported in Fig. 3. Due to the repetitive residues in
the primary structure of the peptide, these ions may
occur by fragmentation of more than one daughter ion.In the CID spectrum of the nonapeptide reported in
Fig. 4 a similar sequence of the ions was identified with
a shift of 127 mass units for the ion at mlz 840 in the
decapeptide CID spectrum, to mf z 713. The absence of
ion at mlz 963 in the latter spectrum suggested that a
terminal Meleu was missing in respect to the decapep-
tide. Other ions identified in the spectrum of decapep-
tide are also shown in Fig. 4. Mass values of ions of the
b series present in the FAB tandem mass spectra deriv-
ing from fragmentation of the protonated molecular
weight of the two peptides ensured for both compounds
an unmodified primary structure with respect to that of
the MeBmtl-Mel.eulo portion of CsA.
Due to the water solubility of the two compounds1H-nuclear magnetic resonance spectra were reiorded
in deuterated water. Unfortunately no clear signals were
obtained, probably due to the presence of various con-
formations of the peptides as observed for CsA by Ko
and Davit. r s
When this work had been already started, three
papers on the treatment of CsA under mild conditions
with aqueous HCI were published.T e However, forma-
tion of open-chain peptides was not mentioned. Under
their hydrolytic conditions the authors of these papers
observed only the isomerization of CsA to a compound
that they identified by comparison of the HpLC reten-
tion time as isoCsA which was previously described by
Rùegger et al.5 to be formed by methanesulphonic acií
via acyl transfer from the peptide nitrogen of MeValll
to the hydroxylic oxygen of MeBmtl (Scheme l). This
compound was also formed under our hydrolytic condi-
tions and was evidenced by HPLC and TLC analysis of
the organic extracts, both showing in addition to
residual cyclosporin (12-15%) one peak representing
22% of CsA used as the substrate (retention time 85
min, Fig. 1, and RF 0.17, respectively). On the other
hand Oliyai and Stellae have reported that degradation
of isoCsA occurs under rather mild acidic conditions
and suggested the possibility that an open-chain peptide
may derive from isoCsA degradation. The reason for
the lack of identification by these authors of the pep-
tides reported here may be the different substrate con-
centration and different conditions used for HPLC
analysis.
Formation of the open-chain peptides described here
by CsA hydrolysis suggests that acidic attack of the
cyclic peptide chain occurs either at the 1-11, 10-11 or
9-10 peptide bond followed by elimination of the
MeValll or both MeValll and Mel.eulo residues.
Apparently no open-chain undecapeptide has been
identified among the compounds formed by acid hydro-
lysis. Nevertheless isoCsA, whose formation implies the
cleavage of the 1-11 peptide bond, was found in the
reaction medium, suggesting that cleavage between the
1 and 11 residues might occur first (Scheme 1) and that
isoCsA might be the stable form of the open-chain
undecapeptide formed under mild acidic conditions
(Scheme 1). Considering the amino acidic sequence of
CsA we may suggest that the nona- and decapeptides
accumulate owing to a lower rate of hydrolysis of N-
methylated amino acids (MeVal and Mel-eu), compared
to those non-methylated (o-Ala and Ala) which follow
in the sequence, and once eliminated would give rise to
octa- and eptapeptides. This hypothesis seems to be
validated by the behaviour of nona- and decapeptides
to the collision with helium atoms. In fact in the CID
spectra of both compounds ions deriving from Ala and
n-Ala degradation are negligible or even absent.
In conclusion, results reported here suggest that the
site of the first hydrolytic attack of the CsA molecule
may be the 1-11 peptide bond. More importantly the
possibility of obtaining from CsA aqueous soluble pep-
tides which may possess biological activity is demon-
strated.
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